Aion Therapeutic Balance Sheet Health
Financial Health criteria checks 3/6
Aion Therapeutic has a total shareholder equity of CA$1.0M and total debt of CA$1.9M, which brings its debt-to-equity ratio to 187.8%. Its total assets and total liabilities are CA$5.9M and CA$4.9M respectively.
Key information
187.8%
Debt to equity ratio
CA$1.94m
Debt
Interest coverage ratio | n/a |
Cash | CA$349.28k |
Equity | CA$1.03m |
Total liabilities | CA$4.85m |
Total assets | CA$5.89m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AION's short term assets (CA$884.6K) do not cover its short term liabilities (CA$4.9M).
Long Term Liabilities: AION has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AION's net debt to equity ratio (154%) is considered high.
Reducing Debt: AION's debt to equity ratio has increased from 51.1% to 187.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AION has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AION is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 26.4% per year.